Back to Search
Start Over
The Most Expensive Drug in the World: To Continue or Discontinue, That Is the Question
- Source :
- Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 33(7)
- Publication Year :
- 2019
-
Abstract
- Tailoring treatment based on genetics and medical history may be preferable for patients with atypical hemolytic uremic syndrome who face lifelong therapy on an expensive medication and increased risk of infection.
- Subjects :
- Columns
Subjects
Details
- ISSN :
- 1945337X
- Volume :
- 33
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Federal practitioner : for the health care professionals of the VA, DoD, and PHS
- Accession number :
- edsair.pmid..........2ede3c2625ce9831fd57d20dc11d0dd1